See All Slides - tctmd.com

Slides

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

Presentation TCT 2017

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Arnold Seto

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Presenter: Gregory P. Fontana, Amar Krishnaswamy

November 01, 2017

Presentation TCT 2017

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

Presenter: Angeles Alonso Garcia

November 01, 2017

Presentation TCT 2017

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Presenter: Gary M. Ansel, Sahil A. Parikh, Andrew J. Klein

November 01, 2017

Presentation TCT 2017

Featured Lecture: Complex PCI Intervention: Unresolved Technical Issues and Opportunities for Innovation

Presenter: Emmanouil S. Brilakis, Christopher E. Buller

November 01, 2017

Presentation TCT 2017

The PLLA-Based Xinsorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Junbo Ge

October 31, 2017

Presentation TCT 2017

Pre and Postconditioning to Enhance Myocardial Salvage: 2017 Status

Presenter: Bernard J. Gersh, Michel Ovize, Graham Nichol

October 31, 2017

Presentation TCT 2017

Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI

Presenter: Navin K. Kapur, Jeffrey W. Moses, Ulrich P. Jorde

October 31, 2017

Presentation TCT 2017

Case #3 Introduction: Degenerative MR With Flail Leaflet(S) in an Intermediate Clinical Risk Patient

Presenter: Samir R. Kapadia, Karl-Heinz Kuck, Olaf Franzen

October 31, 2017

Advertisement

Slides

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch(Statseal): Preliminary Results From the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)

TAVR for Severe AS and Hypertrophic Cardiomyopathy

Is Functional Capacity a Suitable Endpoint for Heart Failure Drug and Device Trials?

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Featured Lecture: Complex PCI Intervention: Unresolved Technical Issues and Opportunities for Innovation

The PLLA-Based Xinsorb

Pre and Postconditioning to Enhance Myocardial Salvage: 2017 Status

Future Devices for Mechanical Circulatory Support in Cardiogenic Shock and High-Risk PCI

Case #3 Introduction: Degenerative MR With Flail Leaflet(S) in an Intermediate Clinical Risk Patient

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content